On Tuesday, March 7th, 908 Devices (NSD: MASS) is scheduled to release its quarterly earnings results before the market opens. Analysts are predicting a loss of ($0.22) per share for the quarter. As of Tuesday morning, the company’s stock price was down 5.0% to $9.10 per share. The company has a fifty-day moving average price of $8.98 and a two-hundred day moving average price of $12.77. Its market capitalization is currently $287.47 million, with a PE ratio of -10.34 and a beta of 0.63.
In insider news, CEO Kevin J. Knopp recently sold a total of 22,622 shares of 908 Devices stock, with the most recent transaction occurring on February 15th. Several hedge funds and institutional investors have also recently modified their holdings of the stock.
A number of equities research analysts have issued ratings and price targets for the company. SVB Leerink lowered its target price from $25.00 to $20.00 and gave 908 Devices an “outperform” rating, while Stephens initiated coverage on the company and assigned it an “overweight” rating and a $14.00 price target.
908 Devices Inc Stock Forecast
According to forecasts from three analysts, the average target price for 908 Devices Inc over the next year is $19.00, with an average analyst ratings of Strong Buy. However, Stock Target Advisor’s analysis of the company is Bearish, based on six negative signals and only two positive signals. As of the last market close, 908 Devices Inc’s stock price was $9.10, representing a decline of 13.74% over the past week, 3.81% over the past month, and 43.65% over the past year.
908 Devices Inc. is a technology company that offers handheld and desktop Mass Spec devices for analyzing unknown materials in various industries, including life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. Its products include MX908, Rebel, and ZipChip solution. The company operates globally and found in 2012, with its headquarters in Boston, Massachusetts.